Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Opportunities and obstacles associated with the Medicare Diabetes Prevention Program
Melanie T Turk1, Natalie D Ritchie, Bailey Norton
1Duquesne University School of Nursing, 518 Fisher Hall, 600 Forbes Ave, Pittsburgh, PA 15282.
Objectives:
CMS has provided full coverage of the Medicare Diabetes Prevention Program (MDPP) since 2018. However, the MDPP's potential to impact public health has been limited by the lack of program suppliers and participants. This study describes the opportunities and obstacles associated with MDPP implementation from the novel perspective of program coordinators across the US.
Study Design:
We conducted a qualitative study with a sample of program coordinators from MDPP suppliers listed in the CMS database.
Methods:
We conducted individual interviews with 12 program coordinators to learn about their experiences becoming a Medicare-designated program supplier and delivering the MDPP. Data were analyzed using the Rapid Group Analysis Process.
Results:
Six themes emerged: 2 about opportunities and 4 about obstacles. Opportunity themes reflected (1) supportive organizational cultures and (2) committed staff who were passionate about and invested in offering the MDPP. Obstacle themes revealed (1) challenges around obtaining Medicare designation, (2) logistics of submitting claims and receiving reimbursement, (3) insufficient payment associated with the pay-for-performance model and Medicare Advantage plans, and (4) overwhelming and conflicting government requirements. Program coordinators offered recommendations to support organizations in providing the MDPP, including peer mentors for onboarding and continued assistance and a more traditional fee-for-service payment model.
Conclusions:
These findings highlight organizational culture as a strength for MDPP implementation and suggest policy changes to address MDPP obstacles. Wider program dissemination is urgently needed to prevent type 2 diabetes among the approximately 5.2 million eligible Medicare beneficiaries.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Drug Dosing: Obese Patients
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

